| Tocilizumab in hospitalized patients with severe Covid-19 pneumonia IO Rosas, N Bräu, M Waters, RC Go, BD Hunter, S Bhagani, D Skiest, ... New England Journal of Medicine 384 (16), 1503-1516, 2021 | 1134* | 2021 |
| Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease DB Beck, MA Ferrada, KA Sikora, AK Ombrello, JC Collins, W Pei, ... New England Journal of Medicine 383 (27), 2628-2638, 2020 | 743 | 2020 |
| Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: a large patient cohort study TI Coulter, A Chandra, CM Bacon, J Babar, J Curtis, N Screaton, ... Journal of Allergy and Clinical Immunology 139 (2), 597-606. e4, 2017 | 547 | 2017 |
| Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: a cohort study E Elkaim, B Neven, J Bruneau, K Mitsui-Sekinaka, A Stanislas, L Heurtier, ... Journal of Allergy and Clinical Immunology 138 (1), 210-218. e9, 2016 | 373 | 2016 |
| Familial autoinflammation with neutrophilic dermatosis reveals a regulatory mechanism of pyrin activation SL Masters, V Lagou, I Jéru, PJ Baker, L Van Eyck, DA Parry, D Lawless, ... Science translational medicine 8 (332), 332ra45-332ra45, 2016 | 303 | 2016 |
| Disease evolution and response to rapamycin in activated phosphoinositide 3-kinase δ syndrome: the european society for immunodeficiencies-activated phosphoinositide 3-kinase δ … ME Maccari, H Abolhassani, A Aghamohammadi, A Aiuti, O Aleinikova, ... Frontiers in immunology 9, 543, 2018 | 291 | 2018 |
| The Ca2+ sensor STIM1 regulates the type I interferon response by retaining the signaling adaptor STING at the endoplasmic reticulum S Srikanth, JS Woo, B Wu, YM El-Sherbiny, J Leung, K Chupradit, L Rice, ... Nature immunology 20 (2), 152-162, 2019 | 275 | 2019 |
| Ligelizumab for chronic spontaneous urticaria M Maurer, AM Giménez-Arnau, G Sussman, M Metz, DR Baker, A Bauer, ... New England Journal of Medicine 381 (14), 1321-1332, 2019 | 253 | 2019 |
| COVID-19 in patients with primary and secondary immunodeficiency: the United Kingdom experience AM Shields, SO Burns, S Savic, AG Richter, A Anantharachagan, ... Journal of Allergy and Clinical Immunology 147 (3), 870-875. e1, 2021 | 234 | 2021 |
| Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response … RJ Mathews, JI Robinson, M Battellino, C Wong, JC Taylor, S Eyre, ... Annals of the rheumatic diseases 73 (6), 1202-1210, 2014 | 220* | 2014 |
| Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans P Tuijnenburg, HL Allen, SO Burns, D Greene, MH Jansen, E Staples, ... Journal of allergy and clinical immunology 142 (4), 1285-1296, 2018 | 210 | 2018 |
| Whole-genome sequencing of a sporadic primary immunodeficiency cohort JED Thaventhiran, H Lango Allen, OS Burren, W Rae, D Greene, ... Nature 583 (7814), 90-95, 2020 | 180 | 2020 |
| Management of suspected immediate perioperative allergic reactions: an international overview and consensus recommendations LH Garvey, P Dewachter, DL Hepner, PM Mertes, S Voltolini, R Clarke, ... British journal of anaesthesia 123 (1), e50-e64, 2019 | 170 | 2019 |
| Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3–selective inhibitor reduces interleukin‐6 production by peripheral blood … J Gillespie, S Savic, C Wong, A Hempshall, M Inman, P Emery, R Grigg, ... Arthritis & Rheumatism 64 (2), 418-422, 2012 | 170 | 2012 |
| British Lung Foundation/United Kingdom Primary Immunodeficiency Network consensus statement on the definition, diagnosis, and management of granulomatous-lymphocytic … JR Hurst, N Verma, D Lowe, HE Baxendale, S Jolles, P Kelleher, ... The Journal of Allergy and Clinical Immunology: In Practice 5 (4), 938-945, 2017 | 169 | 2017 |
| Effect of canakinumab vs placebo on survival without invasive mechanical ventilation in patients hospitalized with severe COVID-19: a randomized clinical trial R Caricchio, A Abbate, I Gordeev, J Meng, PY Hsue, T Neogi, R Arduino, ... Jama 326 (3), 230-239, 2021 | 164 | 2021 |
| Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS MA Ferrada, KA Sikora, Y Luo, KV Wells, B Patel, EM Groarke, ... Arthritis & Rheumatology 73 (10), 1886-1895, 2021 | 160 | 2021 |
| Novel somatic mutations in UBA1 as a cause of VEXAS syndrome JA Poulter, JC Collins, C Cargo, RM De Tute, P Evans, D Ospina Cardona, ... Blood, The Journal of the American Society of Hematology 137 (26), 3676-3681, 2021 | 156 | 2021 |
| Hypomorphic caspase activation and recruitment domain 11 (CARD11) mutations associated with diverse immunologic phenotypes with or without atopic disease B Dorjbal, JR Stinson, CA Ma, MA Weinreich, B Miraghazadeh, ... Journal of Allergy and Clinical Immunology 143 (4), 1482-1495, 2019 | 137 | 2019 |
| Familial Mediterranean fever and related periodic fever syndromes/autoinflammatory diseases S Savic, LJ Dickie, M Battellino, MF McDermott Current opinion in rheumatology 24 (1), 103-112, 2012 | 131 | 2012 |
Thomas ScamblerPhD student, University of Leeds在 leeds.ac.uk 的电子邮件经过验证
